Medicine

Treatment of Acinetobacter infections.

E. Bergogne-Bérézin

1997.2.1EXPERT OPINION ON INVESTIGATIONAL DRUGS

DOI: 10.1517/13543784.6.2.119

tlooto Summary

Novel derivatives of cephalosporins, carbapenems, fluoroquinolones, or completely new antibiotic classes, of which several investigational drugs seem promising, may constitute the future of antibiotic therapy and hence the treatment of Acinetobacter infections.

Abstract

Abstract is not available.

Citation format

BERGOGNE-BÉRÉZIN, E. Treatment of acinetobacter infections. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 1997, 6 2: 119–27.